Clinical Trials Browser

Phase 2 × Lung Neoplasms × pirfenidone × Clear all

NCT05801133 2024-03-15

Pifenidone Prophylactic Therapy for Radiation Lung Injury in Patients Who Have Previously Received Immune Checkpoint Inhibitors

Phase 2 Recruiting

Lung Neoplasms